Cannabis and Public Health: A Study Assessing Regular Cannabis Users Through Health Indicators
This article originally appeared at https://www.liebertpub.com/doi/10.1089/can.2022.0231 Abstract Background and Objective: An increasing number of countries are deciding to regulate the medicinal and/or recreational use of cannabis (Cannabis sativa L.). However, there is a lack of information on the impact of regular consumption of this substance on public health. In this study, for the first time, […]
Meet the “California sober” set
This article originally appeared at https://www.salon.com/2023/01/15/what-does-it-mean-to-be-california-sober/ This month, as many folks attempt to ditch alcohol for “Dry January,” some are picking up cannabis as a replacement. In some circles, skipping booze for weed is a lifestyle colloquially known as going “California sober,” a reflection of the lax attitudes around pot that abound in the Golden […]
Cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety
This article originally appeared at https://www.nature.com/articles/s43856-022-00202-8.epdf?sharing_token=SRm7cZn_w2Nek3b_ZAj-i9RgN0jAjWel9jnR3ZoTv0O1XXfjG2FzIlbbIYsF_ifjMu3OZ6uaWXAhcnDcKI0mLj_TdMOcTh76iHLqwXuySFzTIPfMaKNgkdrFQhxCsflmSg5iDB1C7__ByKoqrf_zDHJpXvEopmNmeUov2bk3M04%3D Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial Authors: Mary Kathryn Dahlgren 1,2,3, Ashley M. Lambros1,2, Rosemary T. Smith1,2, Kelly A. Sagar1,2,3, Celine El-Abboud1,2 & Staci A. Gruber 1,2, Plain language summaryCannabidiol (CBD) is a compound found within […]
Medical cannabis in the treatment of treatment-resistant, chronic cluster headache. A retrospective report
This article originally appeared at https://www.researchgate.net/publication/274891934_EHMTI-0136_Medical_cannabis_in_the_treatment_of_treatment-resistant_chronic_cluster_headache_A_retrospective_report A Mosek*, M Dano, Y Fainmesser, Z HybloomFrom 4th European Headache and Migraine Trust International Congress: EHMTIC 2014Copenhagen, Denmark. 18-21 September 2014 Background Treatment-resistant chronic cluster headache is a debilitating disease. Since 2011 we were able to offer cannabis and we hereby report our experience using cannabis in this […]
Cannabidiol and periodontal inflammatory disease: A critical assessment of Cannabis for dental pain
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/35332345/ Authors: Petr Jirasek 1 , Alexandr Jusku 1 , Vilim Simanek 2 , Jana Frankova 2 , Jan Storch 3 , Jan Vacek 2 PMID: 35332345 DOI: 10.5507/bp.2022.012 Cannabidiol (CBD), a non-psychotropic cannabinoid produced by the genus Cannabis, is a phytoceutical that activates the endocannabinoid system (ECS) through binding to CB1 and CB2 receptors. […]
Can Medical Cannabis or CBD help with Perimenopause-and Menopausal related issues?
This article originally appeared at https://www.truenorthlabs.ch/news/can-medical-cannabis-or-cbd-help-with-perimenopause-and-menopausal-related-issues According to the British Menopause Society, 75% of women are affected by menopausal symptoms – an estimated 1.1 billion worldwide. Until recently, hormone replacement therapy (HRT) was the go-to treatment for menopause, however studies in recent years have shown a steep decline in its use (46% in the USA, […]
Does Cannabis Affect Men and Women Differently? Exploring the Impact of Hormones
This article originally appeared at https://www.truenorthlabs.ch/news/does-cannabis-affect-men-and-women-differently-exploring-the-impact-of-hormones The impact of hormones on the effects of cannabis can be complex and often misunderstood. While past studies have indicated that the effects of cannabis are the same for men and women, there is a growing body of evidence to suggest that hormonal fluctuations throughout the month can have […]
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment
This article originally appeared at https://jamanetwork.com/journals/jamaoncology/article-abstract/2799132 Authors Yuhua Bao, PhD1,2; Hao Zhang, PhD1; Eduardo Bruera, MD3; et alRussell Portenoy, MD4,5,6; William E. Rosa, PhD, MBE, APRN7; M. Carrington Reid, MD, PhD8; Hefei Wen, PhD9 JAMA Oncol. 2023;9(2):206-214. doi:10.1001/jamaoncol.2022.5623 Key Points Question Is medical marijuana legalization associated with opioid-related and pain-related outcomes for adult patients newly diagnosed with cancer and receiving anticancer treatment? Findings This cross-sectional study of 38 189 patients […]
Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use
This article originally appeared at https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2107673 Abstract Purpose: Opioid use rates have dropped as North American patients gain access to medical cannabis, indicating a harm reduction role, yet health outcomes remain mostly unexplored. This study presents self-reported medical cannabis use, perceptions of health functioning, and changes in opioid pain medication use in Florida medical cannabis […]
